Pfizer and GSK to work together on continuous manufacturing

GlaxoSmithKline ($GSK) and Pfizer ($PFE) have both been working on incorporating continuous manufacturing into their production networks. Now they will work on it together. Pfizer announced today that the two had inked a multi-year collaboration for the next-gen design of the portable, continuous, miniature and modular (PCMM) prototype for oral solid dose production that it has already built. Pfizer acknowledged that GSK, which is incorporating continuous manufacturing into a plant in Singapore, has expertise in the field. Release | More

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.